Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 371-380 of 532 for center for individualized medicine

Edit search filters
  1. A Study to Investigate Biomarkers for Phenotyping of Neurodegenerative Disorders

    Jacksonville, FL

  2. A Study for Germline Mutations of Patients with Phyllodes Tumors of the Breast

    Rochester, MN

  3. Detection of Microorganisms and Antibiotic Resistance Genes Using the Curetis UnyveroTM LRT55 Application

    Rochester, MN

  4. DNA (cfDNA) Blood Test to Detect KRAS and Other Clinically Relevant Gene Mutations in Patients with Metastatic Colorectal Cancer

    Rochester, MN

  5. Plasma Proneurotensin as a Predictive Biomarker for Breast Cancer in Genetically Predisposed Patients

    Rochester, MN

  6. A Study of an Integrated Approach to Treating Recurrent Lung Adenocarcinomas Resistant to Tyrosine Kinase Inhibitors

    Rochester, MN

  7. Electrogram-Guided Myocardial Advanced Phenotyping (The eMAP Trial)

    Rochester, MN

  8. A Study of Pancreatic Cancer Risk

    Rochester, MN

  9. Transplant Organ Genomics to Help Prevent Rejection in Kidney Transplant Recipients – RNA-seq Signature Validation

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. A Study to Predict Response to Virotherapy and Immunotherapy by Using an Ex-Vivo Three-Dimensional Patient-Derived Organoid Model of Pediatric Urological Cancers

    Rochester, MN

.

Mayo Clinic Footer